Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins

Journal of General Virology

Volumn 96, Issue 1, 2015, Pages 170-182

  Zhang, Wei ^a,b   Zhang, Lei ^a   Zan, Yanlu ^a   Du, Ning ^a,b   Yang, Yang ^a,b   Tien, Po ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; CYTOKINE; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; INTERLEUKIN 24; MYXOVIRUS RESISTANCE PROTEIN; NUCLEOTIDYLTRANSFERASE; OLIGOADENYLATE SYNTHETASE 2; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRUS RNA; DEAD BOX PROTEIN; DIFFERENTIATION ANTIGEN; IFIH1 PROTEIN, HUMAN; IFITM3 PROTEIN, HUMAN; INTERFERON; LEU-13 ANTIGEN; MEMBRANE PROTEIN; RNA BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INFECTION CONTROL; LOW DRUG DOSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; UBIQUITINATION; VIRUS ENTRY; GENETICS; HELA CELL LINE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; ORTHOMYXOVIRIDAE; RICE STRIPE VIRUS;

ANTIGENS, DIFFERENTIATION; ANTIVIRAL AGENTS; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; HELA CELLS; HUMANS; INTERFERONS; MEMBRANE PROTEINS; MYXOVIRUS RESISTANCE PROTEINS; PHOSPHORYLATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RNA, VIRAL; RNA-BINDING PROTEINS; UBIQUITINATION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84918775342     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.066555-0     Document Type: Article

References (27)

1. Anafu, A. A., Bowen, C. H., Chin, C. R., Brass, A. L. & Holm, G. H. (2013). Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem 288, 17261-17271.
2. Brass, A. L., Huang, I. C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L. & other authors (2009). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254.
3. Diamond, M. S. & Farzan, M. (2013). The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13, 46-57.
4. Everitt, A. R., Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., Sims, J. S. & other authors (2012). IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523.
5. Everitt, A. R., Clare, S., McDonald, J. U., Kane, L., Harcourt, K., Ahras, M., Lall, A., Hale, C., Rodgers, A. & other authors (2013). Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS ONE 8, e80723.
6. Falsey, A. R., Cunningham, C. K., Barker, W. H., Kouides, R. W., Yuen, J. B., Menegus, M., Weiner, L. B., Bonville, C. A. & Betts, R. F. (1995). Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 172, 389-394.
7. García-Sastre, A. & Biron, C. A. (2006). Type 1 interferons and the virus-host relationship: a lesson in de´tente. Science 312, 879-882.
8. Guerrero-Plata, A., Baron, S., Poast, J. S., Adegboyega, P. A., Casola, A. & Garofalo, R. P. (2005). Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol 79, 10190-10199.
9. Handforth, J., Friedland, J. S. & Sharland, M. (2000). Basic epidemiology and immunopathology of RSV in children. Paediatr Respir Rev 1, 210-214.
10. Hsu, N. Y., Ilnytska, O., Belov, G., Santiana, M., Chen, Y. H., Takvorian, P. M., Pau, C., van der Schaar, H., Kaushik-Basu, N. & other authors (2010). Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141, 799-811.
11. Huang, I. C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X. L. & other authors (2011). Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7, e1001258.
12. Jewell, N. A., Vaghefi, N., Mertz, S. E., Akter, P., Peebles, R. S., Jr, Bakaletz, L. O., Durbin, R. K., Flaño, E. & Durbin, J. E. (2007). Differential type I interferon induction by respiratory syncytial virus and influenza A virus in vivo. J Virol 81, 9790-9800.
13. Kolokoltsov, A. A., Deniger, D., Fleming, E. H., Roberts, N. J., Jr, Karpilow, J. M. & Davey, R. A. (2007). Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol 81, 7786-7800.
14. Krzyzaniak, M. A., Zumstein, M. T., Gerez, J. A., Picotti, P. & Helenius, A. (2013). Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog 9, e1003309.
15. Lifland, A. W., Jung, J., Alonas, E., Zurla, C., Crowe, J. E., Jr & Santangelo, P. J. (2012). Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 86, 8245-8258.
16. Lin, R. J., Yu, H. P., Chang, B. L., Tang, W. C., Liao, C. L. & Lin, Y. L. (2009). Distinct antiviral roles for human 29,59-oligoadenylate synthetase family members against dengue virus infection. J Immunol 183, 8035-8043.
17. Ling, Z. H., Tran, K. C. & Teng, M. N. (2009). Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 83, 3734-3742.
18. Lo, M. S., Brazas, R. M. & Holtzman, M. J. (2005). Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79, 9315-9319.
19. Lu, J., Pan, Q. H., Rong, L. W., He, W., Liu, S. L. & Liang, C. (2011). The IFITM proteins inhibit HIV-1 infection. J Virol 85, 2126-2137.
20. Magro, M., Andreu, D., Gómez-Puertas, P., Melero, J. A. & Palomo, C. (2010). Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. J Virol 84, 7970-7982.
21. McCarthy, C. A. & Hall, C. B. (2003). Respiratory syncytial virus: concerns and control. Pediatr Rev 24, 301-309.
22. Mudhasani, R., Tran, J. P., Retterer, C., Radoshitzky, S. R., Kota, K. P., Altamura, L. A., Smith, J. M., Packard, B. Z., Kuhn, J. H. & other authors (2013). IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 87, 8451-8464.
23. Raychoudhuri, A., Shrivastava, S., Steele, R., Kim, H., Ray, R. & Ray, R. B. (2011). ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 85, 12881-12889.
24. Sadler, A. J. & Williams, B. R. (2008). Interferon-inducible antiviral effectors. Nat Rev Immunol 8, 559-568.
25. Sen, G. C. (2001). Viruses and interferons. Annu Rev Microbiol 55, 255-281.
26. Weidner, J. M., Jiang, D., Pan, X. B., Chang, J., Block, T. M. & Guo, J. T. (2010). Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84, 12646-12657.
27. Yount, J. S., Karssemeijer, R. A. & Hang, H. C. (2012). Spalmitoylation and ubiquitination differentially regulate interferoninduced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem 287, 19631-19641.